Data / Form D filings / Avery Therapeutics, Inc.
Avery Therapeutics, Inc.: Form D filings
Avery Therapeutics, Inc., a biotechnology company in Tucson, AZ, filed 2 Form D notices with the SEC between 2017 and 2026. The latest, on September 21, 2026, reports $8.5 million sold of a $15.4 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2500 N. TUCSON BLVD. STE. 140, Tucson, AZ, 85716
- Phone
- (520) 977-4980
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708135
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | New notice | $15,400,000 | $8,468,859 | $6,931,141 | 23 | Aug 19, 2026 | sec.gov |
| Jun 1, 2017 | New notice | $1,500,000 | $500,000 | $1,000,000 | 16 | May 12, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jordan Lancaster | Executive Officer, Director | |
| Lawrence Mehren | Director | |
| Emile Nuwaysir | Director | |
| Steven Goldman | Executive Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- CND Life Sciences, Inc. $6.3 million · Aug 3, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avery Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.